tiprankstipranks
Church & Dwight Company (CHD)
NYSE:CHD

Church & Dwight (CHD) AI Stock Analysis

Compare
897 Followers

Top Page

CH

Church & Dwight

(NYSE:CHD)

74Outperform
Church & Dwight has strong financial performance, with solid revenue growth and cash flow management, supporting a healthy stock score. The technical analysis indicates positive market momentum, though caution is advised due to potential overbought conditions. The high P/E ratio reflects a premium valuation, which could constrain further stock price appreciation. The overall stock score combines these factors, reflecting a well-positioned company with moderate growth potential.
Positive Factors
Innovation and Product Development
Church & Dwight emphasizes innovation and is committed to maintaining its assets, which supports above-average growth.
Market Performance
Top line results beat management's expectations with organic sales growth of 4.2%, indicating strong performance in key areas.
Mergers and Acquisitions
CHD is cash rich and active in mergers and acquisitions, which can support future growth.
Negative Factors
Guidance and Market Reaction
Despite a top-line beat, the stock is expected to trade weaker due to softer than expected guidance.
Inventory and Sales
There is inventory de-stocking at retail, with potential that Q1 organic sales come closer to flat to +2% versus the current guidance.
Profit Margins
Operating profit did miss consensus by 2.5%, but that was more than entirely driven by higher marketing.

Church & Dwight (CHD) vs. S&P 500 (SPY)

Church & Dwight Business Overview & Revenue Model

Company DescriptionChurch & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.
How the Company Makes MoneyChurch & Dwight generates revenue primarily through the manufacture and sale of consumer and specialty products. The consumer products segment is the largest contributor to its revenue, encompassing brands like Arm & Hammer, OxiClean, and Trojan, among others, which are sold through various retail channels, including supermarkets, mass merchandisers, and online platforms. The specialty products division contributes to revenue by supplying performance products to industrial markets and animal nutrition products to the agricultural sector. Key revenue streams include sales from household cleaning products, personal care items, and specialty product solutions. Strategic acquisitions and brand extensions also play a significant role in enhancing their product portfolio and driving growth.

Church & Dwight Financial Statement Overview

Summary
Church & Dwight demonstrates strong financial health with consistent revenue growth and efficient cash flow management. The company has a solid balance sheet with moderate leverage, though rising operational costs have slightly impacted profitability margins. Overall, the company is well-positioned for continued financial stability and growth.
Income Statement
80
Positive
Church & Dwight shows a solid gross profit margin of 45.7% and a net profit margin of 9.6% for the latest year, indicating strong operational efficiency. However, there has been a decline in EBIT margin from 18% in the previous year to 13.2%, suggesting increased operational costs. Revenue growth is healthy at 4.1%, demonstrating steady market expansion.
Balance Sheet
75
Positive
The company's debt-to-equity ratio is 0.51, indicating a moderate level of leverage. Return on equity is 13.4%, showing effective use of equity financing to generate profits. With an equity ratio of 49.1%, Church & Dwight maintains a balanced financial structure, though there's room for improvement in reducing liabilities.
Cash Flow
85
Very Positive
Operating cash flow to net income ratio is robust at 1.97, suggesting strong cash generation capability. Free cash flow has grown by 21%, reflecting efficient capital management. The company maintains a high free cash flow to net income ratio of 1.67, indicative of solid cash reserves for future growth.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
6.11B5.87B5.38B5.19B4.90B
Gross Profit
2.79B2.59B2.25B2.26B2.21B
EBIT
807.10M1.06B597.80M1.08B1.03B
EBITDA
1.09B1.30B826.30M1.30B1.22B
Net Income Common Stockholders
585.30M755.60M413.90M827.50M785.90M
Balance SheetCash, Cash Equivalents and Short-Term Investments
964.10M344.50M270.30M240.60M183.10M
Total Assets
8.88B8.57B8.35B8.00B7.41B
Total Debt
2.20B2.61B2.67B2.56B2.16B
Net Debt
1.24B2.26B2.40B2.32B1.98B
Total Liabilities
4.52B4.71B4.86B4.76B4.39B
Stockholders Equity
4.36B3.86B3.49B3.23B3.02B
Cash FlowFree Cash Flow
976.40M807.10M706.40M875.00M891.40M
Operating Cash Flow
1.16B1.03B885.20M993.80M990.30M
Investing Cash Flow
-183.30M-234.30M-728.60M-682.00M-608.10M
Financing Cash Flow
-343.40M-725.60M-120.90M-252.10M-360.10M

Church & Dwight Technical Analysis

Technical Analysis Sentiment
Negative
Last Price106.09
Price Trends
50DMA
107.83
Negative
100DMA
107.21
Negative
200DMA
104.69
Positive
Market Momentum
MACD
0.12
Negative
RSI
53.90
Neutral
STOCH
89.34
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CHD, the sentiment is Negative. The current price of 106.09 is below the 20-day moving average (MA) of 108.67, below the 50-day MA of 107.83, and above the 200-day MA of 104.69, indicating a neutral trend. The MACD of 0.12 indicates Negative momentum. The RSI at 53.90 is Neutral, neither overbought nor oversold. The STOCH value of 89.34 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CHD.

Church & Dwight Risk Analysis

Church & Dwight disclosed 34 risk factors in its most recent earnings report. Church & Dwight reported the most risks in the “Legal & Regulatory” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Church & Dwight Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
CLCL
79
Outperform
$77.86B27.35704.02%2.08%3.30%26.83%
76
Outperform
$3.43B20.8522.76%2.86%10.22%7.55%
CHCHD
74
Outperform
$27.26B46.7214.25%1.03%4.08%-22.34%
KMKMB
71
Outperform
$48.16B19.23290.03%3.39%-1.83%45.13%
70
Outperform
$45.14B43.899.87%3.45%0.08%-32.67%
CLCLX
66
Neutral
$18.32B40.647616.67%3.27%-1.98%474.83%
63
Neutral
$20.94B14.39-10.05%3.13%1.25%3.11%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CHD
Church & Dwight
106.09
5.19
5.14%
CLX
Clorox
143.86
2.55
1.80%
CL
Colgate-Palmolive
91.66
5.65
6.57%
IPAR
Inter Parfums
104.12
-23.84
-18.63%
KMB
Kimberly Clark
137.91
15.94
13.07%
KVUE
Kenvue, Inc.
22.33
2.85
14.63%

Church & Dwight Earnings Call Summary

Earnings Call Date: Jan 31, 2025 | % Change Since: -0.69% | Next Earnings Date: May 1, 2025
Earnings Call Sentiment Positive
The call highlighted several strong areas of performance, including significant sales and market share growth, particularly in the U.S. and international markets, as well as successful product innovations. However, challenges remain, notably in the gummy vitamins business and increased competition in the litter market. The sentiment reflects a generally positive outlook with some caution in specific areas.
Highlights
Strong Sales Growth
Reported sales growth was 3.8%, exceeding the outlook of 2.5%. Organic sales grew 4.3%, surpassing the 3% outlook with significant volume contribution.
Gross Margin and EPS Performance
Adjusted gross margin expanded by 60 basis points. Adjusted EPS was $0.79, beating the $0.67 outlook.
U.S. Business Success
The U.S. business reported 3.3% organic sales growth, with five of seven power brands gaining market share.
Innovation in Laundry Detergents
ARM & HAMMER Unit Dose consumption grew 16.5%, and new products like Deep Clean and POWER SHEETS show strong consumer interest.
International and Specialty Products Growth
International business delivered 8.1% organic growth, and Specialty Products achieved 7.5% organic growth.
TheraBreath and Hero Brand Performance
THERABREATH grew share in the mouthwash category, and HERO led in the acne patch category with notable market share gains.
Lowlights
Gummy Vitamins Decline
The gummy vitamin category was flat, but the company's consumption was down 10%, leading to a $357 million write-down.
Litter Market Challenges
ARM & HAMMER litter consumption declined 1.5% due to changes in competitor stock situations.
Reported Loss Due to Impairment
A non-cash asset impairment in the vitamin business resulted in a reported EPS loss of $0.31.
Increased Promotional Environment in Litter
Promotions in the litter category increased significantly, primarily driven by a major competitor.
Company Guidance
During the Church & Dwight Q3 2024 earnings call, guidance was provided with a focus on several key metrics. The company reported a 3.8% increase in sales, surpassing their outlook of 2.5%, with organic sales growth at 4.3%. Adjusted gross margin expanded by 60 basis points, and adjusted EPS was $0.79, exceeding the $0.67 forecast. The U.S. business witnessed a 3.3% organic sales growth, driven by a 2.6% volume increase. International business also showed robust growth with an 8.1% rise in organic sales. The company highlighted strong performances from several brands, including ARM & HAMMER, which saw significant growth in both liquid laundry detergent and Unit Dose categories. ARM & HAMMER Deep Clean and POWER SHEETS contributed notably to sales growth. However, the gummy vitamins business faced challenges, leading to a $357 million write-down. Despite this, the company remains optimistic about future innovations and the potential for growth, planning to continue investments in marketing, maintaining marketing expenses above 11% of net sales. The overall guidance remains cautious, particularly around U.S. consumer behavior and category growth rates for Q4.

Church & Dwight Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Church & Dwight Appoints New CFO Amid Leadership Transition
Neutral
Mar 14, 2025

On March 14, 2025, Church & Dwight Co., Inc. announced the appointment of Lee McChesney as the new Executive Vice President and Chief Financial Officer, effective March 24, 2025. This change is part of a leadership transition where the current CFO, Richard Dierker, will become the CEO on April 2, 2025, following Matthew T. Farrell’s retirement. This strategic move is expected to impact the company’s operations and leadership structure significantly.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.